全文获取类型
收费全文 | 8340篇 |
免费 | 706篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 315篇 |
妇产科学 | 186篇 |
基础医学 | 895篇 |
口腔科学 | 382篇 |
临床医学 | 843篇 |
内科学 | 1565篇 |
皮肤病学 | 86篇 |
神经病学 | 765篇 |
特种医学 | 320篇 |
外国民族医学 | 1篇 |
外科学 | 1133篇 |
综合类 | 185篇 |
一般理论 | 9篇 |
预防医学 | 861篇 |
眼科学 | 273篇 |
药学 | 575篇 |
中国医学 | 22篇 |
肿瘤学 | 546篇 |
出版年
2022年 | 52篇 |
2021年 | 78篇 |
2020年 | 76篇 |
2019年 | 92篇 |
2018年 | 104篇 |
2017年 | 94篇 |
2016年 | 101篇 |
2015年 | 111篇 |
2014年 | 137篇 |
2013年 | 229篇 |
2012年 | 294篇 |
2011年 | 366篇 |
2010年 | 210篇 |
2009年 | 200篇 |
2008年 | 348篇 |
2007年 | 425篇 |
2006年 | 402篇 |
2005年 | 390篇 |
2004年 | 390篇 |
2003年 | 334篇 |
2002年 | 333篇 |
2001年 | 316篇 |
2000年 | 310篇 |
1999年 | 257篇 |
1998年 | 100篇 |
1997年 | 95篇 |
1996年 | 86篇 |
1995年 | 77篇 |
1994年 | 89篇 |
1993年 | 86篇 |
1992年 | 258篇 |
1991年 | 242篇 |
1990年 | 215篇 |
1989年 | 183篇 |
1988年 | 189篇 |
1987年 | 173篇 |
1986年 | 167篇 |
1985年 | 153篇 |
1984年 | 115篇 |
1983年 | 120篇 |
1982年 | 76篇 |
1981年 | 57篇 |
1979年 | 83篇 |
1978年 | 74篇 |
1976年 | 55篇 |
1974年 | 60篇 |
1973年 | 80篇 |
1972年 | 51篇 |
1971年 | 59篇 |
1969年 | 53篇 |
排序方式: 共有9069条查询结果,搜索用时 0 毫秒
21.
Severe Glanzmann's thrombasthenia is relatively frequent in Iraqi-Jews and Arabs residing in Israel. We have recently described the mutations responsible for the disease in Iraqi-Jews--an 11 base pair deletion in exon 12 of the glycoprotein IIIa gene, and in Arabs--a 13 base pair deletion at the AG acceptor splice site of exon 4 on the glycoprotein IIb gene. In this communication we show that the Iraqi-Jewish mutation can be identified directly by polymerase chain reaction and gel electrophoresis. With specially designed oligonucleotide primers encompassing the mutation site, an 80 base pair segment amplified in healthy controls was clearly distinguished from the 69 base pair segment produced in patients. Patients from 11 unrelated Iraqi-Jewish families had the same mutation. The Arab mutation was identified by first amplifying a DNA segment consisting of 312 base pairs in controls and of 299 base pairs in patients, and then digestion by a restriction enzyme Stu-1, which recognizes a site that is absent in the mutant gene. In controls the 312 bp segment was digested into 235 and 77 bp fragments, while in patients there was no change in the size of the amplified 299 bp segment. The mutation was found in patients from 3 out of 5 unrelated Arab families. Both Iraqi-Jewish and Arab mutations were detectable in DNA extracted from blood and urine samples. The described simple methods of identifying the mutations should be useful for detection of the numerous potential carriers among the affected kindreds and for prenatal diagnosis using DNA extracted from chorionic villi samples. 相似文献
22.
J H Doroshow M Bertrand E Newman P Multhauf L Leong D Blayney D Goldberg K Margolin B Carr S Akman 《NCI monographs : a publication of the National Cancer Institute》1987,(5):171-174
In this study, 50 patients were randomly assigned to treatment with 5-fluorouracil (FUra) or FUra plus high-dose continuous-infusion folinic acid. Five of 27 evaluable patients in the FUra group versus 10 of 21 patients in the FUra plus folinic acid arm of the study had objective partial remissions, P = 0.02. Time to progression was 3.9 months for FUra and 8.0 months for FUra and folinic acid, P = 0.006; however, median survivals (11.9 versus 14.5 months) were not different in this crossover study. Toxicity in both treatment arms was mild, although patients receiving FUra plus folinic acid experienced significantly more stomatitis than patients treated with FUra alone. This study suggests that high-dose, continuous-infusion folinic acid, which produces a steady-state level of biologically active folates of 10 microM, significantly increases the therapeutic activity of FUra. 相似文献
23.
Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. 总被引:7,自引:4,他引:3 下载免费PDF全文
Human monocytes/macrophages (M psi) were infected with Histoplasma capsulatum yeast cells, and intracellular growth was quantified after 24 h of incubation in medium alone or in medium containing cytokines. Yeast cells multiplied within freshly isolated monocytes, cultured M psi, and alveolar M psi with intracellular generation times of 14.2 +/- 1.4, 18.5 +/- 2.1, and 19.9 +/- 1.9 h (mean +/- standard error of the mean), respectively. Monocytes and M psi inhibited the intracellular growth of yeast cells in response to cytokine supernatant; maximum inhibition was obtained when cytokines were added to cell monolayers immediately after infection. Opsonization of yeast cells in normal serum or in H. capsulatum-immune serum did not affect the intracellular generation time of yeast cells in either control M psi or cytokine-activated M psi. 相似文献
24.
Elsamitrucin (BMY-28090) is an antitumor antibiotic first described in 1985 that has significant oncolytic activity against a number of murine tumors including P388, L1210, B16 and M5076, as well as against MX1 and HCT116 xenografts. Preclinical toxicology studies of elsamitrucin revealed edema of multiple organs associated with hypoproteinemia and, at lethal doses, severe multiorgan toxicity. We conducted a phase I clinical trial (31 patients) of elsamitrucin administered as a 10-min i.v. infusion every 3 weeks. The starting dose (0.6 mg/m2) was 1/3 of the dog low toxic dose. The maximum tolerated dose was 30 mg/m2. Dose-limiting toxicity was reversible hepatic dysfunction manifested by elevated transaminase levels not associated with bilirubin, alkaline phosphatase, or lactate dehydrogenase elevations. Other toxicities included nausea, vomiting, malaise, and phlebitis. Because the hepatic toxicity was brief and reversible, a subsequent study (18 patients) was conducted with elsamitrucin administered every 2 weeks. Reversible grade 3 hepatotoxicity was again observed at 30 mg/m2. Plasma and urine samples from patients receiving doses of 0.6-36 mg/m2 were analyzed for drug content. The maximum plasma concentration and area under the plasma concentration versus time curve values increased linearly with doses up to 25 mg/m2 but not at higher doses. The terminal half-lives, total body clearances, and volume of distribution were 36-60 h, 10-19 liters/h/m2, and 400-1100 liters/m2, respectively. Less than 5% was excreted in the urine in 24 h as parent compound. Bile was collected from one patient with an indwelling biliary catheter. Approximately 22% of the dose was excreted in 48 h, suggesting that biliary excretion of elsamitrucin may be an important route of drug elimination. Based on reversible hepatic toxicity, the phase II recommended dose of elsamitrucin is 25 mg/m2 every 2 weeks. 相似文献
25.
We have studied the human thoracolumbar fascia by using antiserum against neurofilament protein (NFP) and S-100 protein to identify sensory nerve fibers and their endings. Seven surgical specimens from 7 patients were studied with light microscopy. In addition to free nerve endings, two types of encapsulated mechanoreceptors (Ruffini's and Vater-Pacini corpuscles) were identified. These findings support the hypothesis that the thoracolumbar fascia may play a neurosensory role in the lumbar spine mechanism. 相似文献
26.
Existing literature suggests that one of the effects of treatment based on prolonged speech is increased durations of acoustic segments. However, the external validity of the data concerned may be questioned because the data were not based on spontaneous speech samples and were gathered from subjects with unknown treatment histories. With this in mind, the present investigation used young clients with no history of treatment based on prolonged speech and obtained pretreatment and posttreatment acoustic measures from spontaneous speech samples. Acoustic measures showed no significant posttreatment increases in durations of acoustic segments. However, for the acoustic measure of vowel duration and a measure of articulation rate, posttreatment speech samples showed significantly reduced variability. The potential theoretical and practical relevance of these findings is discussed. 相似文献
27.
28.
Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. 总被引:46,自引:0,他引:46 下载免费PDF全文
B Newman M A Austin M Lee M C King 《Proceedings of the National Academy of Sciences of the United States of America》1988,85(9):3044-3048
Segregation analysis of breast cancer in families can provide the logical basis and the specific genetic models for mapping and identifying genes responsible for human breast cancer. Patterns of breast cancer occurrence in families were investigated by complex segregation analysis. In a sample of 1579 nuclear families ascertained through a population-based series of probands, an autosomal dominant model with a highly penetrant susceptibility allele fully explained disease clustering. From the maximum-likelihood Mendelian model, the frequency of the susceptibility allele was 0.0006 in the general population, and lifetime risk of breast cancer was 0.82 among susceptible women and 0.08 among women without the susceptibility allele. Inherited susceptibility affected only 4% of families in the sample: multiple cases of this relatively common disease occurred in other families by chance. The same genetic models, with higher gene frequency, explained disease clustering in an extended kindred at high risk of breast cancer. Evidence for a highly penetrant, autosomal dominant susceptibility allele for breast cancer in a high-risk family and the general population suggests that high-risk families can serve as models for understanding breast cancer in the population as a whole. 相似文献
29.
30.